Mycopathologia 2020: Legacy and Change to Remain Relevant for Content, Creation, and CommunicationMycopathologia 2020: 콘텐츠, 생성 및 커뮤니케이션에 관련성을 유지하기 위한 레거시 및 변경 사항Editorial Published on 2021-05-012022-09-11 Journal: Mycopathologia [Category] SARS, 치료기술, [키워드] 2020 COVID-19 pandemic article articles Brazil change China citation communication content contributed creation decrease focus impact factor legacy Mycopathologia Nature notable pandemic rejection submission suggested transferred USA [DOI] 10.1007/s11046-021-00531-7 PMC 바로가기 [Article Type] Editorial
Recommendations for acceleration of vaccine development and emergency use filings for COVID-19 leveraging lessons from the novel oral polio vaccinePerspective Published on 2021-04-222022-10-04 Journal: NPJ Vaccines [Category] 바이오마커, 임상, [키워드] accelerated biologics Candidates clinical development controls COVID-19 COVID-19 pandemic COVID-19 vaccine COVID-19 vaccine development domain Drug development effort Emergency Emergency use faster functional Guidance help Infectious diseases polio Regulatory Specific submission Vaccine Vaccine development WHO [DOI] 10.1038/s41541-021-00325-4 PMC 바로가기 [Article Type] Perspective
Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019—United States, January 17–February 29, 20202019년 코로나바이러스 질병 조사 대상자의 인구통계학적, 임상적, 역학적 특성—미국, 2020년 1월 17일–2월 29일Research Article Published on 2021-04-152022-09-10 Journal: PLoS ONE [Category] MERS, SARS, 치료기술, [키워드] acute respiratory syndrome coronavirus Asymptomatic caused CDC center changes in Characteristics China clinician Cohort community transmission Complete Confirmed confirmed case confirmed cases consultation Control coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 demographic diagnostic test diagnostic tests disease control evaluation criteria form Healthcare professional identify infections pandemic Pandemics positive presymptomatic prevalence ratios prevention proportion proportions provided public health Quantitative rapid expansion Real-time reverse-transcription PCR report reported respiratory Result SARS-CoV-2 SARS-CoV-2 testing severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Stage submission subsequent Surveillance tested The United States Travel United States [DOI] 10.1371/journal.pone.0249901 PMC 바로가기 [Article Type] Research Article
Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemicResearch Article Published on 2021-02-262022-10-30 Journal: Journal of Clinical and Translational Science [Category] COVID-19, [키워드] academic medical centers access AMC approved Award center change clinical clinician conducted COVID-19 COVID-19 pandemic Critical CTSA determine Device drug Emergency FDA food IDE investigational agent knowledge Modification National New pandemic pathway Patient positioned preapproval access provided public health emergency Regulatory regulatory support required resource response robust role Science submission Support therapy treatments for COVID-19 [DOI] 10.1017/cts.2021.15 PMC 바로가기 [Article Type] Research Article
Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial란디올롤(베타 봉쇄)을 사용한 패혈성 쇼크의 역전에 대한 연구: 무작위 시험을 위한 STRESS-L 연구 프로토콜Intensive Care Published on 2021-02-162022-09-10 Journal: BMJ Open [Category] Fulltext, MERS, 임상, [키워드] 1:1 24 hours adjusted adult intensive & critical care Analysis approved assessment authorisation Beta Beta blocker Beta blockers bpm cardiac function Clinical practice clinical trial clinical trials collaboration competent Consensus defined detect dissemination drug East esmolol Ethics ethics committee failure Final group heart rate improvement include intensive care intensive care unit International International standards landiolol mechanism Medicine Medicines and Healthcare products Regulatory Agency Microbiology minute modulation Mortality Open-label Patient primary endpoint protocol randomisation randomised Randomised trial receive reduce Registered Registration reported required Research Ethics Result Safe Sepsis Septic shock Standard statistics & research methods steering committee submission survival Tachycardia the mean therapy Treatment Trial Trial Steering Committee usual care [DOI] 10.1136/bmjopen-2020-043194 PMC 바로가기 [Article Type] Intensive Care
A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients – a structured summary of a study protocol for a randomized controlled trial증상이 있는 COVID 19 환자의 관리에서 표준 동종 요법 치료와 함께 Siddha 의약품, Kaba Sura Kudineer(KSK) 및 Nilavembu Kudineer(NVK)의 효과를 평가하기 위한 이중 맹검 위약 대조 비교 임상 시험 - 에 대한 연구 프로토콜의 구조화된 요약 무작위 대조 시험Letter Published on 2021-02-112022-09-10 Journal: Trials [Category] MERS, 임상, [키워드] acute respiratory distress syndrome addition Adverse adverse events age age and sex appearance Arm Asymptomatic Bacterial biochemical markers blinded block calculated CAM change Chemical clinical clinical symptom Clinical symptoms clinical trial Complication complications Controlled count COVID COVID 19 COVID 19 patient CRP Ct value CTRI D-dimer Data analysis Date determine diagnose dimer dissemination drug Effect Effectiveness element eligibility eliminated enrolment evaluate exploratory ferritin food GMP group Herbal Hospital stay IL 6 IL6 incidence India Infection infiltration Inflammatory marker inflammatory markers Informed consent investigators involved Laboratory LDH literature management marker Medical Sciences Medicine Medicines Microsoft Excel moderate symptom moderate symptoms morning Night number objective outcome participant Patient patients PCR Placebo Pneumonia profile protocol randomised controlled trial randomization Randomized Randomized controlled trial Ratio recruited recruitment reduce reduction Registered Registration registry reported respiratory respiratory distress Respiratory distress syndrome risk Sample Sample size SARS-CoV-2 secondary Secondary objectives Secondary outcomes severe COVID-19 symptoms Siddha Siddha Medicine smoking SPIRIT guidelines statistician status Study protocol submission Sura symptomatic Taste tea the disease time Total Treatment Trial trial protocol Trial registration value Viral Viral load Viral pneumonia website were blinded [DOI] 10.1186/s13063-021-05041-x PMC 바로가기 [Article Type] Letter
Stress and worry in the 2020 coronavirus pandemic: relationships to trust and compliance with preventive measures across 48 countries in the COVIDiSTRESS global surveyPsychology and Cognitive Neuroscience Published on 2021-02-102022-10-28 Journal: Royal Society Open Science [Category] COVID-19, [키워드] 2020 COVID-19 pandemic Analysis Bayesian analyses behavioural Compliance compliance behaviour condition coronavirus country COVID-19 cultures Data analysis disease distress effort European Factor generate Government help impacted individual Infection International IPA less lockdown manuscript measure Measures Mental Open Science Framework preventive measure PROTECT Protective provided Psychological psychological Impact recruitment Registered researcher response sick social psychology Spread Stage starting Stress submission Support the stage Trust Variation virus was performed while Worry [DOI] 10.1098/rsos.200589 PMC 바로가기 [Article Type] Psychology and Cognitive Neuroscience
UniProt: the universal protein knowledgebase in 2021AcademicSubjects/SCI00010 Published on 2021-01-082022-10-31 Journal: Nucleic Acids Research [Category] Coronavirus, [키워드] adopted annotation automated Community Completeness contribute COVID-19 pandemic functional information Protein protein sequence proteome provided reduce Research resource sequence submission UniProt [DOI] 10.1093/nar/gkaa1100 PMC 바로가기 [Article Type] AcademicSubjects/SCI00010
Antibodies to watch in 20212021년에 주목해야 할 항체Review Published on 2021-01-012022-08-31 Journal: mAbs [Category] 신약개발, 진단, 치료제, [키워드] added addition amivantamab anti-SARS-CoV antibody antibody Antibody therapeutics approval approvals approved array bamlanivimab Cancer Casirivimab clinical study coronavirus disease Coronavirus disease 2019 COVID-19 disorders drug Drug administration Emergency use European European Medicines Agency event faricimab FDA food Food and Drug Administration Healthcare system Immune-mediated immune-mediated disorders. India indication indications information itolizumab Japan mAbs Medicine occur occurred pandemic Potential treatment potential treatments proof Record Registered Regulatory Russia SARS-CoV-2 sodium submission submitted tanezumab Treatment treatments for COVID-19 US Food and Drug Administration [DOI] 10.1080/19420862.2020.1860476 PMC 바로가기 [Article Type] Review
Study protocol for CO vid-19 V ascular s ER vice (COVER) study: The impact of the COVID-19 pandemic on the provision, practice and outcomes of vascular surgeryRegistered Report Protocol Published on 2020-12-302022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] Analysis Care complications COVID-19 COVID-19 pandemic determine deviation form global healthcare increased risk independent intensive care International longitudinal change management multiple comorbidity National network occur operating theatre outcome pandemic Patient performed presenting protocol reduction in Research resource Statistical analysis plan submission Support surgical undergo Vascular vascular surgeon [DOI] 10.1371/journal.pone.0243299 PMC 바로가기 [Article Type] Registered Report Protocol